Dover has entered right into a definitive settlement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
เกจวัดแรงดันราคา will broaden Dover’s biopharma single-use manufacturing providing, which already consists of Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue through the full year 2022.
When the deal closes, Malema will turn out to be part of the PSG business unit within Dover’s Pumps & Process Solutions segment.
“We see an amazing long-term development opportunity in the bioprocessing business pushed by a strong and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as properly as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra environment friendly single-use manufacturing processes supports a strong outlook for our offerings of single-use parts to end-customers. We believe that pairing Malema’s expertise with our current portfolio of single-use pumps for biopharma processing will significantly improve the accuracy and value proposition of our options to our customers.”
“We are methodically building out our biopharma platform via proactive capacity additions, new product growth, and opportunistic acquisitions of highly-attractive area of interest component technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and further strengthens our sensor portfolio with new proprietary expertise. In addition to enticing biopharma functions, we expect robust progress in the semiconductor area on the capability expansion and re-shoring tailwinds.”
Share